CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis
发布时间:2021/12/17 02:20:40

Shen W, Zhang X, Tang J, Zhang Z, Du R, Luo D, Liu X, Xia Y, Li Y, Wang S, Yan S, Yang W, Xiang R, Luo N, Luo Y, Li J. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis. Theranostics. 2021 Jan 1;11(5):2297-2317. 

版权所有:济宁医学院精准医学研究院  地址:济宁市北湖新区荷花路133号科研楼三楼  邮编:272067